Skip to main content
logo
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
904.35
+1.45 (0.16%)
At close: Nov 6, 2026, 4:00 PM EST
900.92
-3.43 (-0.38%)
After-hours: Nov 6, 2026, 7:58 PM EST

Regeneron Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Capitalization
90,75075,71763,43879,28879,19358,18855,36967,75176,639113,465113,391103,43193,40387,20076,96387,69377,05773,64663,69274,33966,029
Market Cap Growth (YoY)
34.04%30.13%14.57%17.03%3.33%-48.72%-51.17%-34.50%-17.95%30.12%47.33%17.95%21.21%18.40%20.84%17.96%16.70%17.05%10.12%50.87%29.49%
Enterprise Value
74,59860,60147,60563,39563,17043,36540,44852,77861,05698,63798,59689,98080,41474,64764,63976,06066,76762,36452,25864,50657,309
Last Close Price
904.35758.27622.81770.59768.90559.40521.53629.11705.671041.411041.20953.49870.08815.27711.82813.99714.75682.43585.60691.89625.62

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
20.0215.7214.6617.9317.5812.7112.4215.0617.3724.3826.2426.8123.6321.8517.9020.9717.7613.7111.209.378.18
Forward PE
11.2512.5012.8717.2217.1114.3614.5014.9015.1921.9123.1821.4919.3618.7517.5219.8717.2916.8214.2115.9511.00
PS Ratio
5.374.484.085.315.524.083.904.815.408.198.417.907.126.666.077.096.335.374.484.504.11
PB Ratio
2.712.262.002.522.531.881.852.312.613.874.023.833.603.503.203.733.403.443.083.733.52
P/TBV Ratio
2.822.352.092.632.641.971.942.402.724.024.183.993.753.653.343.893.543.573.083.733.52
P/FCF Ratio
23.7219.7916.8719.2819.4113.7814.3721.8420.9132.9934.0725.4524.1018.9418.5324.0017.4214.518.099.3710.11
P/OCF Ratio
18.7315.6313.5515.8215.9111.4811.6717.1417.3426.7127.8621.8320.3316.6916.2420.4915.3712.997.548.739.32
PEG Ratio
0.951.041.181.852.931.831.892.330.951.151.374.464.755.008.7679.475.865.865.865.865.17

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
4.423.593.064.254.403.042.853.754.307.127.316.876.135.705.106.155.494.553.673.913.57
EV/EBITDA Ratio
13.2110.7310.1214.4714.889.979.0611.8013.1921.4521.6720.2717.2815.5013.4214.9812.519.147.046.826.18
EV/EBIT Ratio
14.5311.8111.4116.5017.0611.3410.2213.2814.7323.8924.0722.4719.0016.9414.6316.1513.379.597.337.046.37
EV/FCF Ratio
19.5015.8412.6615.4115.4810.2710.5017.0216.6628.6829.6222.1420.7516.2115.5720.8115.0912.296.648.138.78

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.080.080.090.090.100.090.090.090.100.090.100.100.110.110.110.120.120.130.130.140.14
Debt / EBITDA Ratio
0.480.310.440.780.710.540.550.930.640.500.550.760.620.510.600.610.540.510.490.500.24
Debt / FCF Ratio
0.710.710.720.660.730.640.700.870.800.790.810.670.720.590.650.740.630.530.340.340.41
Net Debt / Equity Ratio
-0.48-0.48-0.48-0.50-0.51-0.52-0.49-0.51-0.51-0.53-0.53-0.55-0.52-0.52-0.52-0.52-0.51-0.48-0.55-0.57-0.52
Net Debt / EBITDA Ratio
-2.86-2.86-3.21-3.61-3.74-3.68-3.32-3.34-3.23-3.39-3.26-3.33-2.89-2.70-2.61-2.43-2.17-1.51-1.52-1.21-1.06
Net Debt / FCF Ratio
-4.22-4.22-4.02-3.85-3.89-3.80-3.85-4.81-4.09-4.53-4.45-3.64-3.47-2.82-3.02-3.37-2.61-2.03-1.43-1.44-1.51
Asset Turnover
0.400.400.390.380.370.370.380.390.400.400.400.410.420.440.440.440.450.530.580.750.76
Inventory Turnover
2.933.172.862.812.742.472.442.282.592.392.402.542.642.382.422.582.632.122.072.533.44
Quick Ratio
2.722.722.632.843.283.193.573.903.864.344.434.404.824.314.534.544.164.374.203.952.98
Current Ratio
3.353.353.343.574.134.064.604.934.735.285.445.275.695.185.455.455.065.365.124.763.56
Return on Equity (ROE)
14.95%14.95%14.04%14.55%14.87%15.19%15.34%15.96%15.95%17.17%16.55%15.28%16.26%17.22%19.23%19.27%20.94%27.76%31.76%49.75%54.21%
Return on Assets (ROA)
7.59%7.59%6.53%6.13%5.91%6.16%6.66%6.91%7.31%7.41%7.67%7.77%8.49%9.21%9.55%10.44%11.42%15.83%18.30%25.98%26.39%
Return on Invested Capital (ROIC)
16.31%16.69%13.58%13.42%13.02%14.47%15.69%16.81%18.65%19.38%19.80%20.79%22.28%23.14%23.77%25.86%26.69%37.05%42.97%59.83%60.27%
Return on Capital Employed (ROCE)
13.40%13.40%11.50%10.70%10.20%10.70%11.50%11.70%12.30%12.20%12.60%13.00%14.30%15.40%16.00%17.50%19.20%26.20%29.50%39.30%41.80%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
4.99%6.36%6.82%5.58%5.69%7.87%8.05%6.64%5.76%4.10%3.81%3.73%4.23%4.58%5.59%4.77%5.63%7.29%8.93%10.67%12.23%
FCF Yield
4.22%5.05%5.93%5.19%5.15%7.26%6.96%4.58%4.78%3.03%2.94%3.93%4.15%5.28%5.40%4.17%5.74%6.89%12.35%10.68%9.89%
Dividend Yield
0.42%0.49%0.58%0.46%0.46%0.47%0.33%0.14%-------------
Payout Ratio
8.32%4.91%7.46%13.45%10.98%6.25%6.65%11.60%-------------
Buyback Yield / Dilution
3.11%1.49%2.39%3.15%5.54%7.75%5.89%3.39%-0.94%-2.47%-1.32%-0.97%0.18%-0.53%0.09%-0.80%-0.71%0.97%-2.89%-2.35%-0.89%
Total Shareholder Return
3.53%1.98%2.97%3.61%5.99%8.21%6.22%3.52%-0.94%-2.47%-1.32%-0.97%0.18%-0.53%0.09%-0.80%-0.71%0.97%-2.89%-2.35%-0.89%
SEC Filings: 10-K · 10-Q